INTERLINK(TM) INJECTION SITE

INTERLINK(TM) INJECTION SITE is an FDA 510(k)-cleared medical device (K925126) manufactured by Baxter Healthcare Corp. This device is classified under the General Hospital specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on June 17, 1993. Regulation: 8.